Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer

11 May 2018

Abstract excerpt

// Tetsuya Shindo 1, 2 , Takeshi Niinuma 2 , Naotaka Nishiyama 1 , Nobuo Shinkai 1 , Hiroshi Kitajima 2 , Masahiro Kai 2 , Reo Maruyama 3 , Takashi Tokino 4 , Naoya Masumori 1 and Hiromu Suzuki 2 1 Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan 2 Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan 3 Project for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29849953
DOI: 10.18632/oncotarget.25326

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancerPMID 29849953Read ↗

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell linesSemantic proximity Read ↗

The role of miRNA-424 in various cancers: Focusing on drug resistance and sensitivitySemantic proximity Read ↗

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancerSemantic proximity Read ↗

CircFAM114A2 Inhibits Bladder Cancer Proliferation and Promotes Cisplatin Sensitivity via the miR-222-3p/P27 and miR-146a-5p/P21 CascadesSemantic proximity Read ↗

CircFAM114A2 Inhibits Bladder Cancer Proliferation and Promotes Cisplatin Sensitivity via the miR-222-3p/P27 and miR-146a-5p/P21 CascadesSemantic proximity Read ↗

Expression profile of microRNAs in bladder cancer and their application as biomarkersSemantic proximity Read ↗

Management of advanced bladder cancer in the era of targeted therapies.Semantic proximity Read ↗

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the BladderSemantic proximity Read ↗

The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expressionSemantic proximity Read ↗

miR‑22‑3p enhances multi‑chemoresistance by targeting NET1 in bladder cancer cellsSemantic proximity Read ↗

Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.Semantic proximity Read ↗

The role of microRNA in cisplatin resistance or sensitivitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.